Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 147 (1), 349-360
- https://doi.org/10.1016/j.jaci.2020.04.044
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (RC-2019, RF-2013 GR-2013-02356568)
- Associazione Italiana per la Ricerca sul Cancro
- Horizon 2020 Framework Programme
- Horizon 2020
- H2020 Marie Skłodowska-Curie Actions (800924)
This publication has 42 references indexed in Scilit:
- Selective inhibition of low-affinity memory CD8+ T cells by corticosteroidsThe Journal of Experimental Medicine, 2019
- Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunityNature Medicine, 2019
- Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate-like invariant T lymphocytesBrain, Behavior, and Immunity, 2019
- Glucocorticoids promote breast cancer metastasisNature, 2019
- Immune regulation by glucocorticoids can be linked to cell type–dependent transcriptional responsesThe Journal of Experimental Medicine, 2019
- Neuroendocrine regulation of innate lymphoid cellsImmunological Reviews, 2018
- Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cellsNature Immunology, 2018
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative PotentialCell, 2015
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical applicationNature Immunology, 2013
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsThe New England Journal of Medicine, 2005